Bicycle Therapeutics Ltd (BCYC) Ownership

24.90 ↑0.35 (1.43%)
As of March 28, 2024, 3:59pm EST.

Institutional Ownership

Paradigm Biocapital Advisors LP is the biggest individual institutional holder of Bicycle Therapeutics Ltd (BCYC), owning a total of 3.7 million shares. Combined, the top 37 institutional holders of BCYC own 107.43% of the company with a total of 38.7 million shares.

In the latest ownership report on December 31st 2023, the top 37 institutional holders increased their combined ownership of BCYC by 1.9 million shares. 8 institutions bought 3,737,764 total additional shares and increased their ownership by an average of 950.54%. However 7 institutions sold 1,797,198 total shares and decreased their ownership by an average of 17.91%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Bicycle Therapeutics Ltd increased by a net total of 1,940,566 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Paradigm Biocapital Advisors LP9.786%1.776%3,707,00164,6942023-12-31
Deep Track Capital, LP9.215%0.000%3,490,50602023-12-31
Jefferies Financial Group Inc5.143%0.000%1,948,00002023-12-31
Baker Bros Advisors LP4.726%112.178%1,790,390946,5762023-12-31
Tybourne Capital Management (HK) Ltd4.357%28.748%1,650,320368,5002023-12-31
First Light Asset Management, LLC4.093%-25.129%1,550,471-520,3822023-12-31
Armistice Capital, LLC4.055%53.600%1,536,000536,0002023-12-31
Morgan Stanley - Brokerage Accounts2.717%-36.536%1,029,225-592,5242023-12-31
Polar Capital Holdings PLC2.652%-0.689%1,004,535-6,9652023-12-31
Westfield Capital Management Company, LP2.422%0.000%917,304917,3042023-12-31
Suvretta Capital Management, LLC2.414%-9.545%914,476-96,5002023-12-31
Candriam Luxembourg S.C.A.2.295%-30.640%869,258-384,0032023-12-31
RA Capital Management, LLC2.112%0.000%800,00002023-12-31
BNP Paribas Investment Partners SA2.067%22.175%782,998142,1162023-12-31
Verition Fund Managegment, LLC1.955%-19.189%740,539-175,8432023-12-31
AXA SA1.463%-3.648%554,086-20,9812023-12-31
BlackRock Inc1.324%158.457%501,623307,5392023-12-31
Bank of America Corp1.218%7,227.370%461,331455,0352023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Paradigm Biocapital Advisors LP9.786%1.776%3,707,00164,6942023-12-31
Deep Track Capital, LP9.215%0.000%3,490,50602023-12-31
Ridgeback Capital Investments L.p.7.538%4.619%2,264,801100,0002022-12-31
Jefferies Financial Group Inc5.143%0.000%1,948,00002023-12-31
Baker Bros Advisors LP4.726%112.178%1,790,390946,5762023-12-31
Tybourne Capital Management (HK) Ltd4.357%28.748%1,650,320368,5002023-12-31
First Light Asset Management, LLC4.093%-25.129%1,550,471-520,3822023-12-31
Armistice Capital, LLC4.055%53.600%1,536,000536,0002023-12-31
Point72 Asset Management, L.P.3.431%171.862%1,299,500821,5002023-09-30
BRAIDWELL LP3.405%0.000%1,289,8721,289,8722023-09-30
RTW INVESTMENTS, LLC4.189%-1.386%1,258,587-17,6892022-12-31
Morgan Stanley - Brokerage Accounts2.717%-36.536%1,029,225-592,5242023-12-31
Polar Capital Holdings PLC2.652%-0.689%1,004,535-6,9652023-12-31
Samlyn Capital, LLC3.288%-23.661%987,888-306,1972022-12-31
Westfield Capital Management Company, LP2.422%0.000%917,304917,3042023-12-31
Suvretta Capital Management, LLC2.414%-9.545%914,476-96,5002023-12-31
HHG PLC2.415%-28.907%910,930-370,3942023-09-30
SV Life Sciences Advisers, LLC3.021%0.000%907,03202022-09-30
Candriam Luxembourg S.C.A.2.295%-30.640%869,258-384,0032023-12-31
Eventide Asset Management, LLC2.842%0.000%853,80002022-12-31
RA Capital Management, LLC2.112%0.000%800,00002023-12-31
Sio Capital Management, LLC2.112%-17.729%796,933-171,7382023-09-30
BNP Paribas Investment Partners SA2.067%22.175%782,998142,1162023-12-31
Verition Fund Managegment, LLC1.955%-19.189%740,539-175,8432023-12-31
T. Rowe Price Associates, Inc.1.572%99.490%593,053295,7682023-09-30
AXA SA1.463%-3.648%554,086-20,9812023-12-31
Logos Global Management LP1.416%-30.667%520,000-230,0002023-06-30
BlackRock Inc1.324%158.457%501,623307,5392023-12-31
Bank of America Corp1.218%7,227.370%461,331455,0352023-12-31
Deerfield Management Co1.190%0.000%448,753448,7532023-09-30
Soleus Capital Management, L.P.1.122%0.000%411,80002023-06-30
Nomura Holdings Inc1.090%0.000%400,000400,0002023-06-30
Two Sigma Investments LLC1.282%114.668%380,654203,3322022-06-30
Millennium Management LLC1.124%104.265%333,701170,3342022-06-30
FMR Inc0.782%-23.964%287,147-90,5002023-03-31
Two Sigma Advisers, LLC0.885%-36.729%262,700-152,5002022-09-30
PURA VIDA INVESTMENTS, LLC0.718%16.383%213,12130,0002022-09-30

Mutual Fund Ownership

Polar Capital Biotech S Inc is the biggest individual fund holder of Bicycle Therapeutics Ltd (BCYC), owning a total of 1 million shares. Combined, the top 45 mutual fund holders of BCYC own 28.68% of the company with a total of 10.3 million shares.

In the latest ownership report on February 29th 2024, the top 45 fund holders increased their combined ownership of BCYC by 39 thousand shares. 1 funds bought 40,000 total additional shares and increased their ownership by an average of 30.77%. However 1 funds sold 925 total shares and decreased their ownership by an average of 0.45%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Bicycle Therapeutics Ltd increased by a net total of 39,075 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Belfius Equities Cure C Cap1.468%0.000%555,93402024-02-29
iShares Biotechnology ETF0.541%-0.449%205,100-9252024-02-29
Handelsbanken Hälsovård Tema (A1 SEK)0.449%30.769%170,00040,0002024-02-29

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Polar Capital Biotech S Inc2.640%0.000%1,000,00002024-01-31
Eventide Healthcare & Life Sciences I2.842%0.000%853,80002022-12-31
BNP Paribas Health Cr Innovtr Cl Cap1.584%-0.216%600,020-1,2992024-01-31
Candriam Global Equities Oncology1.534%-24.351%580,934-187,0002023-12-31
Belfius Equities Cure C Cap1.468%0.000%555,93402024-02-29
Janus Global Life Science A USD1.445%2.999%433,81912,6322022-12-31
Westfield Capital Mgt Co Sm-Cap Gr Eq1.040%0.000%394,050394,0502023-12-31
Harbor Small Cap Growth Instl1.040%0.000%394,050394,0502023-12-31
Janus Henderson Global Life Sciences1.023%-18.864%385,754-89,6882023-09-30
Janus Henderson Global Life Sciences D1.023%-18.864%385,754-89,6882023-09-30
Janus Selection Global Life Science AUSD0.791%-20.449%298,274-76,6732023-09-30
BlackRock Health Sciences Term Trust0.735%0.000%278,27002024-01-31
AXA Framlington Health R Inc0.726%-2.045%273,983-5,7192023-12-31
AXA Framlington Health Fund - R Income0.723%0.000%273,98302024-01-31
Candriam Eqs L Biotech C USD Cap0.722%-5.203%273,295-15,0002024-01-31
UTM IM GBP AXA Framlington Biotech0.709%0.000%268,72402024-01-31
Fidelity® Select Biotechnology0.706%0.000%266,34702023-11-30
BNP Paribas US Small Cap Classic R0.610%26.313%230,88648,0972024-01-31
iShares Biotechnology ETF0.541%-0.449%205,100-9252024-02-29
T. Rowe Price Health Sciences0.532%-56.109%201,468-257,5482023-12-31
Janus Henderson Glb Life Scn I2 USD0.515%-4.491%194,237-9,1342023-11-30
Fidelity® Small Cap Growth0.575%0.000%170,82402022-11-30
Handelsbanken Hälsovård Tema (A1 SEK)0.449%30.769%170,00040,0002024-02-29
T. Rowe Price New Horizons0.509%-0.098%150,971-1482022-09-30
Kennedy Small Cap Growth0.372%50.075%140,89047,0102023-12-31
MEDICAL BioHealth EUR Acc0.363%0.000%137,53002023-11-30
Kennedy Micro Cap0.363%0.000%137,454137,4542023-12-31
Fidelity Select Biotechnology0.280%-60.185%106,047-160,3002024-01-31
Allianz Biotechnologie P EUR0.264%0.000%99,82002024-01-31
Loomis Sayles Small Cap Growth CIT D0.327%0.000%96,93596,9352022-03-31
AlphaCentric LifeSci Healthcare I0.238%53.846%90,00031,5002023-12-31
DWS ESG Biotech LC0.233%67.853%88,00235,5742023-10-31
AZ Fd1 AZ Equity - America A-AZ Fd Acc0.209%-0.935%79,116-7472024-01-31
Allianz Biotechnologie A EUR0.220%0.000%66,04002023-01-31
Belfius Equities Glob Health Care C$ Cap0.209%24.000%62,00012,0002022-07-31
APO Medical Opportunities R0.161%0.000%60,67502023-11-30
Fidelity® Small Cap Growth K60.149%0.000%44,13502022-11-30
Harbor Disruptive Innovation Instl0.149%-11.168%44,112-5,5462022-09-30
Janus Henderson Horizon Bio E2 USD Acc0.133%-4.956%39,797-2,0752023-02-28
L&S Equity Growth0.116%-7.683%34,725-2,8902022-12-31
Janus Henderson Hrzn Biotec E2 USD0.113%2.080%33,9166912023-05-31
Bellevue Biotech DT CHF0.087%0.000%26,00026,0002023-02-28
TD Health Sciences - I0.079%51.328%23,5868,0002022-12-31
Bellevue (Lux) Bellevue Biotech I USD0.077%-36.111%23,000-13,0002022-12-31
Fidelity® NASDAQ Composite Index®0.057%0.000%17,14402023-04-30

Discussions

Please log in or register to share your thoughts.

haltdaytrader

$BCYC the greatest stock of all time
will not bow to the shorts
oh yeah

0 Like Report
HousewifeTrader

$BCYC do what the markets tells you to do not the other way around

0 Like Report